Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia

• Status: Completed
• Trial end date: 2005-01-01

Summary

The purpose of this study is to compare intramuscular Olanzapine and intramuscular Haloperidol in changing of agitation in patients with schizophrenia

• Phase: Phase 3

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Haloperidol; Haloperidol decanoate; Olanzapine